Delivery Order SPE2DB20D2002-SPE2DB24FL16Q

Award Date 1/16/24
Potential Completion Date 1/17/24
Potential Value $5.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of ROTARIX vaccine oral syringes (1.5 ml) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $52,131.70, is a firm-fixed-price delivery order with a completion date of July 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is for the delivery of ROTARIX vaccine oral syringes (1.5 mL) to the Defense Logistics Agency (DLA). The contract, valued at $7,420.77, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,168.31 firm fixed-price delivery order is for the supply of 4,568,239,230 units of the ROTARIX vaccine oral syringe, 1.5 ml. The contract has a period of performance through May 14, 2025 and is not set aside for any particular business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award issued by the Defense Logistics Agency (DLA) is for the delivery of Rotarix Vaccine Oral Syringes (1.5ml) to Amerisourcebergen Drug Corp. The contract award, valued at $1,514.90, is a firm fixed-price delivery order with a period of performance through December 5, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. The contract has no set-aside designation, indicating open...
This federal contract award, valued at $13,686.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of ROTARIX vaccine oral syringes, 1.5ML, with a completion date of May 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of ROTARIX VACCINE ORAL SYRINGE 1.5ML to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,906.64 and a period of performance through March 12, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order, with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award is for the procurement of the ROTARIX vaccine oral syringe 1.5ML by the Defense Logistics Agency (DLA). The contract has a total ceiling value of $7,398.96 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is March 4, 2025. There is no set-aside designation for this contract. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of the ROTARIX vaccine oral syringes (1.5 mL). The firm-fixed-price delivery order, valued at $10,682.65, has a period of performance through February 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is for the delivery of the ROTARIX vaccine oral syringes (1.5 mL) to the Defense Logistics Agency (DLA). The contract, valued at $3,258.64, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and an ultimate completion date of November 8, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of ROTARIX VACCINE ORAL SYRINGE 1.5ML to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $4,429.98, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 15, 2025. The contract is not set aside and was awarded through open competition....
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB24FL16Q
    Delivery Order

This federal contract award is for the delivery of ROTARIX vaccine oral syringes (1.5 ml) to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,123.41 and is a firm fixed-price delivery order with a completion date of January 17, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is part of Amerisourcebergen's broader role as a key vendor for federal healthcare programs, particularly within the Department of Defense and Department of Veterans Affairs.

Generated 2/27/25, 11:39 AM